Evaluating the Quality Of Life in Dry Eye Patients and Identifying Risk Factors in this Study
Keywords:
Dry Eye, Risk Factors, Symptoms, and General health quality of life QuestionnaireAbstract
Background: Dry eye illness (DED), a typical multifactorial condition, influences a huge level of individuals around the world.
Aim: The purpose of this study is to assess the health and quality of life of individuals with dry eye and identify risk factors associated with patients.
Methods: We collected information from 66 dry eye patients. 60% of the patients were men, and 40% were women, and their ages varied from 24 to 58. Every patient who took part in this study was monitored at the different hospitals in the Ophthalmology Department in Iraq during February 2023 – April 2024. A questionnaire measuring dry eye signs, visual acuity, and quality of life was given to each patient. The influence of risk variables for the long-term quality of life for people with dry eye was assessed by a univariate evaluation.
Results: 66 dry eye patients were included in this study. Patients in the age group (46–58) years had a significant enrolled rate compared with other groups, which got 50%. the most symptomatic factor was singing sensation in the eyes with 25.76%, where TBUT was 4.7, and S1T was 4.2, corneal fluorescein staining was 0.4 in the right eye, while TBUT was 4.64 and S1T was 4.6 corneal fluorescein staining was 0.2. In the assessment of health quality of life, we found general health was (49.18), general vision (62.67), ocular pain (65.82), color vision (97.60), ocular symptoms (- 0.57), SAS (51.45), and SDS (53.30).
Summary: Dry eye patients' vision-related quality of life was compromised and linked to anxiety and discouragement, further solidifying the illness as a serious general medical condition deserving of greater resources and attention.
References
Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. TFOS DEWS II Definition and Classification Report. Ocul Surf. 2017;15:276–283.
Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol. 2009;3:405–412.
Uchino M, Schaumberg D. Dry Eye Disease: Impact on Quality of Life and Vision. Curr Ophthalmol Rep 2013;1:51–7.
Findlay Q, Reid K. Dry eye disease: when to treat and when to refer. Aust Prescr 2018; 41:160–3.
Javadi MA, Feizi S. Dry eye syndrome. J Ophthalmic Vis Res 2011;6:192–8.
Jain S, Bhavsar A, Bhavsar S. A review on recent advances in dry eye: Pathogenesis and management. Oman J Opthalmol 2011;4:50.
Dana R, Bradley JL, Guerin A, Pivneva I, Stillman IÖ, Evans AM, et al. Estimated Prevalence and Incidence of Dry Eye Disease Based on Coding Analysis of a Large, All-age United States Health Care System. Am J Ophthalmol. 2019;202:47–54.
Song P, Xia W, Wang M, Chang X, Wang J, Jin S, et al. Variations of dry eye disease prevalence by age, sex, and geographic characteristics in China: a systematic review and meta-analysis. J Glob Health. 2018;8:020503.
The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5:93–107.
Courtin R, Pereira B, Naughton G, Chamoux A, Chiambaretta F, Lanhers C, et al. Prevalence of dry eye disease in visual display terminal workers: a systematic review and meta-analysis. BMJ Open. 2016;6:e009675.
Ahn J, Ryu SJ, Song J, Kim HR. Shift Work and Dry Eye Disease in the Korean Working Population: A Population-Based Cross-Sectional Study. Int J Environ Res Public Health. 2021;18:5492.
Liu J, Dong Y, Wang Y. Vitamin D deficiency is associated with dry eye syndrome: a systematic review and meta-analysis. Acta Ophthalmol. 2020;98:749–754.
Yoo TK, Oh E. Diabetes mellitus is associated with dry eye syndrome: a meta-analysis. Int Ophthalmol. 2019;39:2611–2620.
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6: e1000097.
Song P, Rudan D, Zhu Y, Fowkes FJI, Rahimi K, Fowkes FGR, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019;7:e1020–e1030
Wells G, Shea B, O’Connell D. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa (ON): Ottawa Hospital Research Institute; 2009.
Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7: 177–88.
Ades AE, Lu G, Higgins JP. The interpretation of random-effects meta-analysis in decision models. Med Decis Making. 2005; 25: 646–54.
Deeks JJ, Higgins JPT, Altman DG. Analyzing data and undertaking meta-analyses. In: Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions 5.0.1. Oxford, UK: The Cochrane Collaboration: 2008; chap 9.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.
Tobias A. Assessing the influence of a single study in meta-analysis. Stata Tech Bull. 1999;47:15–7.
Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ. 2003; 326: 219.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50: 1088–1101.
Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118:1264–8.
Lee AJ, Lee J, Saw SM, Gazzard G, Koh D, Widjaja D, et al. Prevalence and risk factors associated with dry eye symptoms: a population-based study in Indonesia. Br J Ophthalmol. 2002;86:1347–51.
Chia EM, Mitchell P, Rochtchina E, Lee AJ, Maroun R, Wang JJ. Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. Clin Exp Ophthalmol. 2003;31:229–32.
Sahai A, Malik P. Dry eye: prevalence and attributable risk factors in a hospital-based population. Indian J Ophthalmol. 2005;53:87–91.
Nichols JJ, Sinnott LT. Tear film, contact lens, and patient-related factors associated with contact lens-related dry eye. Invest Ophthalmol Vis Sci. 2006;47:1319–28.
Uchino M, Schaumberg DA, Dogru M, Uchino Y, Fukagawa K, Shimmura S, et al. Prevalence of dry eye disease among Japanese visual display terminal users. Ophthalmology. 2008;115:1982–8.
Lu P, Chen X, Liu X, Yu L, Kang Y, Xie Q, et al. Dry eye syndrome in elderly Tibetans at high altitude: a population-based study in China. Cornea. 2008;27:545–51.
Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: estimates from the Physicians’ Health Studies. Arch Ophthalmol. 2009;127:763–8.
Viso E, Rodriguez-Ares MT, Gude F. Prevalence of and associated factors for dry eye in a Spanish adult population (the Salnes Eye Study). Ophthalmic Epidemiol. 2009;16: 15–21.
Jie Y, Xu L, Wu YY, Jonas JB. Prevalence of dry eye among adult Chinese in the Beijing Eye Study. Eye (Lond). 2009;23:688–93.
Guo B, Lu P, Chen X, Zhang W, Chen R. Prevalence of dry eye disease in Mongolians at high altitude in China: the Henan eye study. Ophthalmic Epidemiol. 2010;17:234–41.
Kim KW, Han SB, Han ER, Woo SJ, Lee JJ, Yoon JC, et al. Association between depression and dry eye disease in an elderly population. Invest Ophthalmol Vis Sci. 2011;52: 7954–8.
